1994
DOI: 10.1297/cpe.3.supple5_192
|View full text |Cite
|
Sign up to set email alerts
|

Human Growth Hormone (GH) Stimulates Erythropoietin (EPO) Secretion in Anemic Patients with Chronic Renal Failure (CRF)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1995
1995
1995
1995

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 8 publications
(1 reference statement)
0
1
0
Order By: Relevance
“…It was also reported that the anemia associated with pituitary dwarfism was improved by GH replacement therapy [14]. We recently reported that GH had a stimulatory effect on EPO secretion, since GH administration for only 3 days resulted in an increase in serum EPO and the reticulocyte count in anemic patients with renal failure [15]. GH stimulates erythropoiesis in bone marrow in vivo [16] and the proliferation of erythroid progenitor cells in vitro, directly or indirectly through insulin-like growth factor I (IGF-I) [17,18].…”
Section: Discussionmentioning
confidence: 99%
“…It was also reported that the anemia associated with pituitary dwarfism was improved by GH replacement therapy [14]. We recently reported that GH had a stimulatory effect on EPO secretion, since GH administration for only 3 days resulted in an increase in serum EPO and the reticulocyte count in anemic patients with renal failure [15]. GH stimulates erythropoiesis in bone marrow in vivo [16] and the proliferation of erythroid progenitor cells in vitro, directly or indirectly through insulin-like growth factor I (IGF-I) [17,18].…”
Section: Discussionmentioning
confidence: 99%